Xenon Pharmaceuticals (XENE) Other financing activities (2013 - 2014)
Xenon Pharmaceuticals (XENE) reported Other financing activities of $228000.0 for Q4 2014, up 776.92% year-over-year from $26000.0 in Q4 2013, and down 60.35% quarter-over-quarter from $575000.0 in Q3 2014.
Xenon Pharmaceuticals (XENE) Other financing activities (2013 - 2014) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 2 years of Other financing activities data on file, last reported at $228000.0 in Q4 2014.
- Other financing activities for Q4 2014 came in at $228000.0, up 776.92% year-over-year; the trailing twelve-month figure through Dec 2014 was $1.5 million (changed N/A YoY), and the FY2014 annual result was $1.5 million, down 44.03% from the prior year.
- Other financing activities eased to $228000.0 in Q4 2014 per XENE's latest filing, from $575000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $575000.0 in Q3 2014 and troughed at $26000.0 in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Xenon Pharmaceuticals | 4.61 Bn | 4.61 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 228,000.00 |
| Dec 31, 2014 | 228,000.00 |
| Sep 30, 2014 | 575,000.00 |
| Sep 30, 2014 | 575,000.00 |
| Jun 30, 2014 | 332,000.00 |
| Jun 30, 2014 | 332,000.00 |
| Mar 31, 2014 | 398,000.00 |
| Mar 31, 2014 | 398,000.00 |
| Dec 31, 2013 | 26,000.00 |
| Dec 31, 2013 | 26,000.00 |